In contrast to primary tumor cells, normal immune cells, which express CD32, barely induced degranulation of iNKT cells, indicating that anti-iNKT TCR mAb-bound iNKT cells recognize and target tumors specifically without affecting normal cells. The gene discussed is FCGR2A; the disease is neoplasm.